Hes1 is involved in the self-renewal and tumourigenicity of stem-like cancer cells in colon cancer

Scientific Reports

Volumn 4, Issue , 2014, Pages

  Gao, Fei ^a   Zhang, Yuqin ^b   Wang, Shengchun ^b   Liu, Yuanqiang ^a   Zheng, Lin ^b   Yang, Jianquan ^a   Huang, Wei ^a   Ye, Yanfen ^c   Luo, Weiren ^b   Xiao, Dong ^b  

^a THE FIRST AFFILIATED HOSPITAL OF JINAN UNIVERSITY   (China)

^b SOUTHERN MEDICAL UNIVERSITY   (China)

^c WANNAN MEDICAL COLLEGE   (China)

Author keywords

[No Author keywords available]

Indexed keywords

BASIC HELIX LOOP HELIX TRANSCRIPTION FACTOR; CD133 ANTIGEN; GLYCOPROTEIN; HES1 PROTEIN, HUMAN; HOMEODOMAIN PROTEIN; LEUKOCYTE ANTIGEN; MESSENGER RNA; PEPTIDE;

ADENOCARCINOMA; ANIMAL; BIOSYNTHESIS; CANCER STEM CELL; CANCER TRANSPLANTATION; CELL TRANSFORMATION; COLON TUMOR; FLOW CYTOMETRY; GENE EXPRESSION REGULATION; GENETICS; HCT116 CELL LINE; HUMAN; METABOLISM; MOUSE; MULTICELLULAR SPHEROID; NUDE MOUSE; PATHOLOGY; TUMOR CELL CULTURE; UPREGULATION; XENOGRAFT;

ADENOCARCINOMA; ANIMALS; ANTIGENS, CD; BASIC HELIX-LOOP-HELIX TRANSCRIPTION FACTORS; CELL TRANSFORMATION, NEOPLASTIC; COLONIC NEOPLASMS; FLOW CYTOMETRY; GENE EXPRESSION REGULATION, NEOPLASTIC; GLYCOPROTEINS; HCT116 CELLS; HOMEODOMAIN PROTEINS; HUMANS; MICE; MICE, NUDE; NEOPLASM TRANSPLANTATION; NEOPLASTIC STEM CELLS; PEPTIDES; RNA, MESSENGER; SPHEROIDS, CELLULAR; TRANSPLANTATION, HETEROLOGOUS; TUMOR CELLS, CULTURED; UP-REGULATION;

EID: 84893819232     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep03963     Document Type: Article

References (21)

1. Mackillop, W. J., Ciampi, A., Till, J. E. & Buick, R. N. A stem cell model of human tumour growth: implications for tumour cell clonogenic assays. J. Natl. Cancer Inst. 70, 9-16 (1983). (Pubitemid 13138325)
2. Ricci-Vitiani, L. et al. Identification and expansion of human colon-cancerinitiating cells. Nature 445, 111-115 (2007). (Pubitemid 46067311)
3. O'Brien, C. A., Pollett, A., Gallinger, S. & Dick, J. E. A human colon cancer cell capable of initiating tumour growth in immunodeficient mice. Nature 445, 106-110 (2007). (Pubitemid 46067310)
4. Haraguchi, N. et al. Characterization of a side population of cancer cells from human gastrointestinal system. Stem Cells 24, 506-513 (2006). (Pubitemid 44464754)
5. Burkert, J., Otto, W. R. & Wright, N. A. Side populations of gastrointestinal cancers are not enriched in stem cells. J. Pathol. 214, 564-573 (2008). (Pubitemid 351482271)
6. Harada, K. et al. Notch1-Hes1 signalling axis in the tumourigenesis of biliary neuroendocrine tumours. J. Clin. Pathol. 66, 386-391 (2013).
7. Kabos, P., Kabosova, A. & Neuman, T. Blocking HES1 Expression Initiates GABAergic Differentiation and Induces the Expression of p21CIP1/WAF1 in Human Neural Stem Cells. J. Biol. Chem. 277, 8763-8766 (2002). (Pubitemid 34952939)
8. Piper, M. et al. NFIA Controls Telencephalic Progenitor Cell Differentiation through Repression of the Notch Effector Hes1. J. Neurosci. 30, 9127-9139 (2010).
9. Schreck, K. C. et al. The Notch Target Hes1 Directly Modulates Gli1 Expression and Hedgehog Signaling: A Potential Mechanism of Therapeutic Resistance. Clin. Cancer Res. 16, 6060-6070 (2010).
10. Katoh, M. & Katoh, M. Notch signaling in gastrointestinal tract (review). Int. J. Oncol. 30, 247-251 (2007).
11. Roy, S. &Majumdar, A. P. Signaling in colon cancer stem cells. J. Mol. Signal. 7, 11 (2012).
12. Frea, S. et al. Notch and Wnt signals cooperatively control cell proliferation and tumourigenesis in the intestine. P.N.A.S. 106, 6309-6314 (2009).
13. Zeki, S. S., Graham, T. A. & Wright, N. A. Stem cells and their implications for colorectal cancer. Nat. Rev. Gastroenterol Hepatol. 8, 90-100 (2011).
14. Gerger, A. et al. Common Cancer Stem Cell Gene Variants Predict Colon Cancer Recurrence. Clin. Cancer Res. 17, 6934-6943 (2011).
15. Fabrizi, E., Martino, S., Pelacchi, F. & Lucia, R. V. Therapeutic implications of colon cancer stem cells. World J. Gastroenterol. 16, 3871-3877 (2010).
16. Feng, H. L. et al. Expression of CD133 correlates with differentiation of human colon cancer cells. Cancer Biology & Therapy. 9, 216-223 (2010).
17. Horst, D., Kriegl, L., Engel, J., Kirchner, T. & Jung, A. CD133 expression is an independent prognostic marker for low survival in colorectal cancer. Br. J. Cancer. 99, 1285-1289 (2008).
18. Zhou, S. et al. The ABC transporter Bcrp1/ABCG2 is expressed in a wide variety of stem cells and is a molecular determinant of the side-population phenotype. Nat. Med. 7, 1028-1034 (2001). (Pubitemid 32937383)
19. Li, D. W. et al. Expression level of Bmi-1 oncoprotein is associated with progression and prognosis in colon cancer. J. Cancer Res. Clin. Oncol. 136, 997-1006 (2010).
20. Huang, E. H. et al. Aldehyde Dehydrogenase 1 Is a Marker for Normal and Malignant Human Colonic Stem Cells (SC) and Tracks SC Overpopulation during Colon Tumourigenesis. Cancer Res. 69, 3382-3389 (2009).
21. Lin, C. W. et al. Epithelial Cell Adhesion Molecule Regulates Tumour Initiation and Tumourigenesis via Activating Reprogramming Factors and Epithelial- Mesenchymal Transition Gene Expression in Colon Cancer. J. Biol. Chem. 287, 39449-39459 (2012).